Wang Ai-Qing, Geng Mei-Ju, Zhu Ming-Qing, Chen Li
Soochow University Experiment Center, Suzhou, Jiangsu Province, China.
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011 Dec;19(6):1374-7.
This study was aimed to investigate the immunophenotypic characteristics of 109 cases of B-cell chronic lymphoid leukemia (B-CLL) so as to provide evidences for the diagnosis and therapy of B-CLL, and for the detection of the minimal residual disease and its prognosis. Immunophenotyping was performed in 109 patients of B-CLL by two/three color multiparameter flow cytometry analysis using a panel of monoclonal antibodies. The results showed that in 109 cases of B-CLL, all cases expressed CD19, the positive ratios of other B lineage antigen such as CD20, CD22 and CD23 were 95.40%, 94.50%, 86.20% respectively. None of the B-CLL cases expressed CD10. The expression ratio of FMC-7 and CD38 in 105 cases of B-CLL were 28.60% and 36.20%. Among the B-CLL cases the CD5(+) cells amounted to 86.23%, CD5(-) cells amounted to 13.76%, ZAP-70 protein was expressed in 12 out of 50 patients. It is concluded that immunophenotypic data are very useful for the diagnosis and detection of minimal residual disease of B-CLL, and the relationship between the immunophenotypic characteristics and the prognosis of B-CLL needs further study.
本研究旨在探讨109例B细胞慢性淋巴细胞白血病(B-CLL)的免疫表型特征,为B-CLL的诊断和治疗、微小残留病的检测及其预后提供依据。采用一组单克隆抗体,通过两色/三色多参数流式细胞术分析对109例B-CLL患者进行免疫表型分析。结果显示,109例B-CLL患者均表达CD19,其他B系抗原如CD20、CD22和CD23的阳性率分别为95.40%、94.50%、86.20%。所有B-CLL患者均不表达CD10。105例B-CLL患者中FMC-7和CD38的表达率分别为28.60%和36.20%。在B-CLL患者中,CD5(+)细胞占86.23%,CD5(-)细胞占13.76%,50例患者中有12例表达ZAP-70蛋白。结论:免疫表型数据对B-CLL的诊断和微小残留病的检测非常有用,B-CLL免疫表型特征与预后的关系有待进一步研究。